| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |